Dr. Everett has become the program leader at Johns Hopkins in pediatric biomarker discovery, initially in sickle cell disease and subsequently in other pediatric clinical conditions (birth injury, congenital heart disease repair, ECMO, prematurity and pulmonary hypertension).
He is the principal investigator (PI) or co-PI on multiple NIH- funded R01 studies and two proteomic focused contracts for the NICHD National Children’s Study.
Everett A, Ignjatovic V. "Paediatrics and proteomics: back to the beginning." Proteomics Clin Appl. 2014 Dec;8(11-12):805-6. doi: 10.1002/prca.201470064.
Goldenberg NA, Everett AD, Graham D, Bernard TJ, Nowak-Göttl U. "Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions." Proteomics Clin Appl. 2014 Dec;8(11-12):828-36. doi: 10.1002/prca.201400062.
Nies MK, Ivy DD, Everett AD. "The untapped potential of proteomic analysis in pediatric pulmonary hypertension." Proteomics Clin Appl. 2014 Dec;8(11-12):862-74. doi:
Lance EI, Casella JF, Everett AD, Barron-Casella E. "Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease." Proteomics Clin Appl. 2014
Laflam A, Joshi B, Brady K, Yenokyan G, Brown C, Everett A, Selnes O, McFarland E, Hogue CW. "Shoulder surgery in the beach chair position is associated with diminished cerebral autoregulation but no differences in postoperative cognition or brain injury biomarker levels compared with supine positioning: the anesthesia patient safety foundation beach chair study." Anesth Analg. 2015 Jan;120(1):176-85. doi: 10.1213/ANE.0000000000000455.